Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Laxmikant B. Borse"'
Autor:
Mithun Rudrapal, Ashwini K. Mishra, Laxmi Rani, Khomendra K. Sarwa, James H. Zothantluanga, Johra Khan, Mehnaz Kamal, Santwana Palai, Atul R. Bendale, Swati G. Talele, Vasim T. Pathan, Laxmikant B. Borse, Vishnu S. Neharkar, Pravat K. Sahoo
Publikováno v:
Molecules, Vol 27, Iss 24, p 8706 (2022)
Advancement in nanotechnology has unleashed the therapeutic potentials of dietary polyphenols by enhancing bioavailability, improving biological half-life, and allowing site-specific drug delivery. In this review, through citation of relevant literat
Externí odkaz:
https://doaj.org/article/1a4692fe62db4406b0586d8ecb0c0b3d
Publikováno v:
Biosciences Biotechnology Research Asia. 19:943-954
The foremost intention of present research was the preparation and assessment of mouth dissolving formulation Rivaroxaban and its validation. During present work, this tablet was formulated by straight compression technique by means of Cros-carmellos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ca4714e429dfc40aabf4030acd125b5
https://doi.org/10.13005/bbra/3043
https://doi.org/10.13005/bbra/3043
Autor:
Gayatri Kakad, Sandhya L. Borse, Atul R. Bendale, Laxmikant B. Borse, Vaishali D. Naphade, Anil G. Jadhav
Publikováno v:
Asian Pacific Journal of Health Sciences. 9:208-213
This study developed and validated a new, sensitive, appropriate, clear, accurate, and robust reversed-phase high-performance liquid chromatography (RP-HPLC) method for determining Rufinamide in bulk medication and tablet formulation. The separation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2bcc806e65fae5368cfe2e7299f793b
https://doi.org/10.21276/apjhs.2022.9.4s1.38
https://doi.org/10.21276/apjhs.2022.9.4s1.38
Publikováno v:
International Journal of Current Research and Review. 14:85-92
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48eab31f328dd6fa8080a57cbc16edd2
https://doi.org/10.31782/ijcrr.2022.14205
https://doi.org/10.31782/ijcrr.2022.14205
Publikováno v:
Drug Research
The current outbreak of novel Coronavirus Disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major pandemic situation and a catastrophe for humans. COVID-19 is a severe infectious disease particularly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7aa780676d105933f7b7100b5993eae
https://doi.org/10.1055/a-1217-2397
https://doi.org/10.1055/a-1217-2397